- Home
- XYF vs ORMP Comparison
XYF vs ORMP Comparison
Compare XYF & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XYF | ORMP |
|---|---|---|
| Founded | 2014 | 2002 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 190.7M | 165.3M |
| IPO Year | 2018 | 2010 |
Fundamental Metrics
Financial Performance| Metric | XYF | ORMP |
|---|---|---|
| Price | $4.85 | $4.26 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 104.6K | ★ 189.4K |
| Earning Date | 05-18-2026 | 05-14-2026 |
| Dividend Yield | ★ 11.34% | 6.51% |
| EPS Growth | N/A | ★ 412.50 |
| EPS | N/A | ★ 0.91 |
| Revenue | N/A | ★ $2,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $0.90 | $4.59 |
| Revenue Growth | N/A | ★ 49.25 |
| 52 Week Low | $3.30 | $1.98 |
| 52 Week High | $20.36 | $5.01 |
Technical Indicators
Market Signals| Indicator | XYF | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 50.20 | 63.74 |
| Support Level | $4.48 | $3.21 |
| Resistance Level | $5.11 | $5.01 |
| Average True Range (ATR) | 0.21 | 0.17 |
| MACD | -0.01 | 0.06 |
| Stochastic Oscillator | 28.99 | 94.87 |
Price Performance
Historical ComparisonAbout XYF X Financial each representing six
X Financial is a Cayman Islands-based technology-driven personal finance company. Along with its subsidiaries, the firm provides diversified investment opportunities to investors in China through its wealth management platform, Xiaoying Wealth Management. Loan products offered by the company include Xiaoying Card Loan, Xiaoying Preferred Loan, and Xiaoying Housing Loan. The company generates revenue from loan facilitation service, post-origination service, guarantee services provided and financing income.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.